Macrovascular involvement in systemic sclerosis: Evidence of correlation with disease activity

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.71, 2012, Pages

  Zeng, Yong ^a,b   Li, Mengtao ^a   Xu, Dong ^a   Hou, Yong ^a   Wang, Qian ^a   Fang, Quan ^a   Sun, Qiuning ^a   Zhang, Shuyang ^a   Zeng, Xiaofeng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NONE   (China)

Author keywords

Atherosclerosis; Disease activity; Peripheral arterial disease; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE PRESSURE; PULSE WAVE; RAYNAUD PHENOMENON; RISK ASSESSMENT; SYSTEMIC SCLEROSIS;

EID: 84867353983     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rodnan GP, Myerowitz RL, Justh GO: Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) 1980; 59: 393-408.
2. Hettema ME, Bootsma H, Kallenberg CG: Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 2008; 47: 578-583.
3. Mok MY, Chiu SS, Lo Y et al.: Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 2009; 38: 381-385.
4. Akram MR, Handler CE, Williams M et al.: Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 2006; 45: 1395-1398.
5. Stücker M, Quinna S, Memmel U et al.: Macroangiopathy of the upper extremities in progressive systemic sclerosis. Eur J Med Res 2000; 5: 295-302.
6. Hasegawa M, Nagai Y, Tamura A, Ishikawa O: Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis. Br J Dermatol 2006; 155: 1159-1164.
7. Au K, Singh MK, Bodukam V et al.: Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 2011; 63: 2078-2090.
8. Lijmer JG, Hunink MG, Van Den Dungen JJ et al.: ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 1996; 22: 391-398.
9. Hirsch AT, Haskal ZJ, Hertzer NR et al.: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654.
10. Ho M, Veale D, Eastmond C, Nuki G, Belch J: Macrovascular disease and systemic sclerosis. Ann Rheum Dis 2000; 59: 39-43.
11. Stafford L, Englert H, Gover J, Bertouch J: Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 1998; 57: 476-479.
12. Taylor MH, Mcfadden JA, Bolster MB, Silver RM: Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol 2002; 29: 102-106.
13. Park JH, Sung YK, Bae SC, Song SY, Seo HS, Jun JB: Ulnar artery vasculopathy in systemic sclerosis. Rheumatol Int 2009; 29: 1081-1086.
14. Clark CE, Campbell JL, Evans PH, Millward A: Prevalence and clinical implications of the inter-arm blood pressure difference: A systematic review. J Hum Hypertens 2006; 20: 923-931.
15. Clark CE, Campbell JL, Powell RJ: The interarm blood pressure difference as predictor of cardiovascular events in patients with hypertension in primary care: cohort study. J Hum Hypertens 2007; 21: 633-638.
16. Yamashina A, Tomiyama H, Arai T et al.: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.
17. Koji Y, Tomiyama H, Ichihashi H et al.: Comparison of ankle-brachial pressure index and pulse wave velocity as markers of the presence of coronary artery disease in subjects with a high risk of atherosclerotic cardiovascular disease. Am J Cardiol 2004; 94: 868-872.
18. Boin F, Franchini S, Colantuoni E, Rosen A, Wigley FM, Casciola-Rosen L: Independent association of anti-beta(2)- glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients. Arthritis Rheum 2009; 60: 2480-2489.
19. Szamosi S, Csiki Z, Szomják E et al.: Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage? Clin Rev Allergy Immunol 2009; 36: 145-149.
20. Marie I, Borg JY, Hellot MF, Levesque H: Plasma D-dimer concentration in patients with systemic sclerosis. Br J Dermatol 2008; 158: 392-395.
21. Bartoli F, Angotti C, Fatini C et al.: Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford) 2007; 46: 772-775.
22. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
23. THE WORLD HEALTH ORGANIZATION WESTERN PACIFIC REGION, THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF OBESITY, THE INTERNATIONAL OBESITY TASK FORCE: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia, Health Communications Australia Pty Limited 2000: 17.
24. Timár O, Soltész P, Szamosi S et al.: Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 2008; 35: 1329-1333.
25. Szucs G, Tímár O, Szekanecz Z et al.: Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications. Rheumatology (Oxford) 2007; 46: 759-762.
26. Gu D, He J, Duan X et al.: Body weight and mortality among men and women in China. JAMA 2006; 295: 776-783.
27. De Marco PJ, Weisman MH, Seibold JR et al.: Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early dijffuse systemic sclerosis trial. Arthritis Rheum 2002; 46: 2983-2989.
28. Clements PJ, Hurwitz EL, Wong WK et al.: Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000; 43: 2445-2454.
29. Steen VD, Medsger TA JR.: Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001; 44: 2828-2835.